✦ LIBER ✦

Malignant hyperthermia associated with a typical central core disease

✍ Scribed by Satoshi Akazawa; Reiju Shimizu; Haruyuki Kasuda; Shinichi Nakao; Terutoshi Nakamigawa

Publisher: Springer
Year: 1987
Tongue: English
Weight: 527 KB
Volume: 1
Category: Article
ISSN: 0913-8668
DOI: 10.1007/s0054070010105

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Central core disease and malignant hyper

Central core disease and malignant hyperthermia syndrome

✍ John P. Frank; Yadollah Harati; Dr. Ian J. Butler; Thomas E. Nelson; Charles I. 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 792 KB

Ryanodine receptor mutations in malignan

Ryanodine receptor mutations in malignant hyperthermia and central core disease

✍ Tommie V. McCarthy; Kathleen A. Quane; Patrick J. Lynch 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 259 KB 👁 2 views

Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle that manifests in response to anesthetic triggering agents. Central core disease (CCD) is a myopathy closely associated with MH. Both MH and CCD are primarily disorders of calcium regulation in skeletal muscle. The ryanodin

Mutations in RYR1 in malignant hyperther

Mutations in RYR1 in malignant hyperthermia and central core disease

✍ Rachel Robinson; Danielle Carpenter; Marie-Anne Shaw; Jane Halsall; Philip Hopki 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 531 KB

The RYR1 gene encodes the skeletal muscle isoform ryanodine receptor and is fundamental to the process of excitation-contraction coupling and skeletal muscle calcium homeostasis. Mapping to chromosome 19q13.2, the gene comprises 106 exons and encodes a protein of 5,038 amino acids. Mutations in the

Ryr1 mutations in canadian subjects with

Ryr1 mutations in canadian subjects with malignant hyperthermia and central core disease

✍ Natasha Kraeva; Wanda Frodis; Mary Lou Crossan; K. Nolan; JCP Loke; DH MacLennan 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 French ⚖ 19 KB

Central core disease and susceptibility

Central core disease and susceptibility to malignant hyperthermia in a single family

✍ Lara Colleoni; Giorgia Melli; Lucia Morandi; Paola Cudia; Stefania Romaggi; Rena 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 213 KB

RYR1 mutations causing central core dise

RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes

✍ Rachel L. Robinson; Collin Brooks; Sarah L. Brown; F. Richard Ellis; P. Jane Hal 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB

Malignant hyperthermia (MH) and central core disease (CCD) are autosomal dominant disorders of skeletal muscle. Susceptibility to MH is only apparent after exposure to volatile anesthetics and/or depolarizing muscle relaxants. CCD patients present with diffuse muscular weakness but are also at risk